Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ardent Animal Health provides commercial veterinary regenerative products such as autologous adipose-derived stem cell therapy (Acti-Stem Therapy) and PRP kits (PureVet PRP), plus oncology services (custom cancer vaccines such as K9-ACV and pathology/genomic testing integration), used widely in companion animals; these products are marketed based on clinical case experience and literature but are not FDA-approved and were cited in a 2024 FDA warning letter as unapproved new animal drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Ardent Animal Health.